CAJ | 학술논문

结直肠癌在远处转移中肝转移比例达50％～75％,但只有10％～15％的肝转移患者能获得手术切除的机会,且易复发.选择性体内放疗(SIRT)是用于肝脏定向的新型放射疗法,对于不可切除的结直肠癌肝转移,该疗法单独或联合其他疗法可缩小癌灶,延长患者生存期,并可能改善总生存率.
결직장암재원처전이중간전이비례체50％～75％,단지유10％～15％적간전이환자능획득수술절제적궤회,차역복발.선택성체내방료(SIRT)시용우간장정향적신형방사요법,대우불가절제적결직장암간전이,해요법단독혹연합기타요법가축소암조,연장환자생존기,병가능개선총생존솔.
Colorectal cancer is the third high incidence of tumor in the world,and liver is one of the most common sites of distant metastasis.Liver metastasis accounts for 50％-75％ in distant metastasis.Only about 10％ -15％ of patients are candidates for resection,and the recurrence is easy.Selective internal radiation therapy is a new type of radiotherapy.It is partial and liver-targeted.For unresectable colorectal liver metastasis,selective internal radiation therapy alone or in combination with other therapies can reduce cancer focus,prolong the survival,and maybe improve overall survival.